Stockreport

Compugen Monetizes Portion of Rilvegostomig Future Royalties to AstraZeneca for Up to $90 Million [Yahoo! Finance]

Compugen Ltd. - Ordinary Shares  (CGEN) 
Last compugen ltd. - ordinary shares earnings: 2/20 07:05 am Check Earnings Report
US:NASDAQ Investor Relations: cgen.com/investors/overview
PDF Monetization includes an upfront payment of $65 million and a potential additional $25 million upon reaching the next milestone Compugen retains majority of royalties [Read more]